Turtle Creek Wealth Advisors’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Buy
220,000
+50,000
+29% +$108K 0.03% 271
2025
Q4
$400K Hold
170,000
0.03% 254
2025
Q3
$520K Hold
170,000
0.05% 207
2025
Q2
$474K Hold
170,000
0.06% 174
2025
Q1
$610K Hold
170,000
0.09% 100
2024
Q4
$536K Hold
170,000
0.12% 65
2024
Q3
$479K Hold
170,000
0.1% 104
2024
Q2
$209K Hold
170,000
0.05% 150
2024
Q1
$135K Hold
170,000
0.03% 154
2023
Q4
$162K Buy
+170,000
New +$167K 0.05% 161

Other funds holding CLOV

Turtle Creek Wealth Advisors's CLOV Position: Q1 2026 in Review

Turtle Creek Wealth Advisors increased its Clover Health Investments (CLOV) stake by 29% in Q1 2026, buying an estimated $108K and bringing the position to 220,000 shares worth $387K. The position accounts for 0.03% of the portfolio, ranked #271.

Turtle Creek Wealth Advisors first reported a position in CLOV in Q4 2023 and has held it in 10 quarters since. The position peaked at $610K in Q1 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Turtle Creek Wealth Advisors held 220,000 shares of Clover Health Investments worth $387K as of Q1 2026.
  • Turtle Creek Wealth Advisors bought 50,000 Clover Health Investments shares in Q1 2026, an estimated $108K.
  • Clover Health Investments made up 0.03% of Turtle Creek Wealth Advisors's portfolio in Q1 2026, its #271 holding.
  • Turtle Creek Wealth Advisors first reported a position in Clover Health Investments in Q4 2023 and has held it in 10 quarters since.
  • Turtle Creek Wealth Advisors's Clover Health Investments position peaked at $610K in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.